Description
Composition- Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg
Mode of Action- Combines insulin secretion, improved insulin sensitivity and reduced hepatic glucose production for comprehensive diabetes management.
USPs- Triple antidiabetic action; improves insulin sensitivity; effective in insulin-resistant patients.
Prescribing Specialties- Diabetologist, General Physician
